ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SABSW SAB Biotherapeutics Inc

0.0399
-0.0001 (-0.25%)
After Hours
Last Updated: 07:45:13
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
SAB Biotherapeutics Inc SABSW NASDAQ Equity Warrant
  Price Change Price Change % Share Price Last Trade
-0.0001 -0.25% 0.0399 07:45:13
Open Price Low Price High Price Close Price Previous Close
0.04 0.0399 0.0449 0.0399 0.04
more quote information »

Recent News

Date Time Source Heading
31/5/202407:15EDGAR2Form DEF 14A - Other definitive proxy statements
21/5/202421:30EDGAR2Form 8-K - Current report
21/5/202407:45GLOBESAB Biotherapeutics Announces Q1 2024 Financial Results and..
21/5/202406:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/5/202421:15GLOBESAB Biotherapeutics Appoints Jay Skyler, MD, to the Board of..
16/4/202421:15GLOBESAB Biotherapeutics Provides SAB-142 Trial Update
08/4/202421:15GLOBESAB Biotherapeutics to Present at INNODIA Annual Meeting
04/4/202422:15GLOBESAB Biotherapeutics to Present at the Needham Virtual..
29/3/202422:15GLOBESAB Biotherapeutics Reports Full Year 2023 Operating and..
26/3/202401:15GLOBESAB Biotherapeutics Announces Clinical Partnership with..
24/2/202400:00GLOBESAB Biotherapeutics to Present at the BIO CEO & Investor..
09/2/202400:00GLOBESAB Biotherapeutics to Present at the Oppenheimer..
02/2/202423:30GLOBESAB Biotherapeutics Announces Executive Leadership Change
24/1/202409:58GLOBESAB Biotherapeutics Regains Compliance with Nasdaq Minimum..
03/1/202408:30GLOBESAB Biotherapeutics Announces 1-for-10 Reverse Stock Split
29/11/202323:30GLOBESAB Biotherapeutics Announces Commencement of the HUMAN..
20/11/202323:30GLOBESAB Biotherapeutics Appoints Katie Ellias to the Board of..
14/11/202323:30GLOBESAB Biotherapeutics Announces Completion of $67.1 Million..
14/11/202323:15GLOBESAB Biotherapeutics Announces Q3 2023 Financial Results and..
09/11/202323:30GLOBESAB Biotherapeutics to Present at Piper Sandler Healthcare..
24/10/202322:30GLOBESAB Biotherapeutics Appoints Michael G. King Jr. as Chief..
19/10/202322:30GLOBESAB Biotherapeutics Receives Australian Approval to Commence..
05/10/202322:30GLOBESAB Biotherapeutics Approves Appointment of Andrew Moin to..
02/10/202322:30GLOBESAB Biotherapeutics Announces Private Placement of up to..
21/8/202322:30GLOBESAB Biotherapeutics Provides Company Update for Q2..
21/6/202322:30GLOBESAB Biotherapeutics Presents Positive IND-Enabling GLP..

Your Recent History

Delayed Upgrade Clock